Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
#What Is The Projected Market Size Of The Atrial Fibrillation Devices Market By 2029?
The market size for atrial fibrillation devices has seen significant expansion over the past few years. This market is projected to expand from $7.69 billion in 2024 to reach $8.60 billion in 2025, driven by a compound annual growth rate (CAGR) of 11.8%. Factors contributing to its expansion historically include an increasing elderly population, a greater need for minimally invasive cardiac procedures, supportive government initiatives, and the spread of telecardiology services.
The atrial fibrillation devices market is projected to expand significantly over the coming years. This market is anticipated to reach a valuation of $13.28 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 11.5%. This forecasted expansion stems from factors such as increased spending on healthcare, a rising count of multi-specialty hospitals, greater acceptance of modern treatment options, enhanced regulatory backing for device authorizations, and an increasing need for less invasive surgical procedures. Key developments influencing this period encompass technological innovations, improvements in remote monitoring devices, the incorporation of artificial intelligence for diagnostic purposes, progress in minimally invasive ablation systems, and new capabilities in mapping and imaging.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25704&type=smp
Which Industry Drivers Are Expected To Accelerate The Atrial Fibrillation Devices Market From 2025 To 2029?
The increasing prevalence of cardiovascular diseases is projected to propel the growth of the atrial fibrillation device market. Cardiovascular diseases refer to disorders impacting the heart and blood vessels, such as heart attacks, strokes, and hypertension. The incidence of cardiovascular diseases is rising globally, attributed to the surge in obesity and diabetes, alongside widespread sedentary lifestyles and poor dietary habits. Atrial fibrillation (AFib) devices play a crucial role in managing cardiovascular diseases by detecting, monitoring, and treating irregular heart rhythms, which are often linked to or result from underlying heart conditions. For instance, in June 2024, data published by the American Heart Association, a US-based public health organization, indicated that as high blood pressure is expected to increase from 51.2% to 61.0%, the number of individuals diagnosed with cardiovascular diseases is projected to rise from 128 million in 2020 to over 184 million by 2050. Consequently, the expansion of cardiovascular diseases is driving the growth of the atrial fibrillation device market.
What Are The Emerging Segments Gaining Attention In The Atrial Fibrillation Devices Market?
The atrial fibrillation devices market covered in this report is segmented –
1) By Device Type: Implantable Devices, External Devices, Catheter-Based Devices
2) By Product: Electrophysiology Ablation Catheters, Cardiac Monitors Or Implantable Loop Recorder, Electrophysiology Diagnostic Catheters, Mapping And Recording Systems, Access Devices, Intracardiac Echocardiography, Left Atrial Appendage Closure Devices, Other Products
3) By Technology: Radiofrequency, Cryotherapy, Ultrasound, Other Technologies
4) By Distribution Channel: Direct Sales, Distributors, Online Sales
5) By End-Use: Hospitals, Cardiac Centers, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Implantable Devices: Implantable Cardioverter Defibrillators, Pacemakers, Insertable Cardiac Monitors
2) By External Devices: External Defibrillators, Holter Monitors, Mobile Cardiac Telemetry Devices, Electrocardiogram Monitors
3) By Catheter-Based Devices: Radiofrequency Ablation Catheters, Cryoablation Catheters, Laser Ablation Catheters, Mapping and Navigation Systems, Transseptal Access Devices
What Trends Are Redefining The Atrial Fibrillation Devices Market Dynamics?
Leading firms within the atrial fibrillation devices market are prioritizing technological advancements, such as patient-centric clinical decision support tools, with the goal of enhancing diagnostic precision, personalizing treatment plans, and improving overall patient outcomes. These patient-centric clinical decision support tools are digital solutions designed to assist healthcare professionals in tailoring treatment decisions by analyzing individual patient data. An illustration of this occurred in August 2023, when GE HealthCare Technologies Inc., a US-based medical technology company, launched CardioVisio for Atrial Fibrillation. This digital clinical decision support tool is engineered to streamline clinician workflows and facilitate precision care for patients with atrial fibrillation. It enables healthcare providers to visualize the progression of AFib, including previous diagnoses, treatments, medications, and associated conditions. Furthermore, the platform offers guideline-based therapy recommendations, which aids in reducing diagnostic errors and streamlining clinical decision-making. CardioVisio effectively organizes fragmented patient information into an accessible format, thereby easing the burden on medical staff and supporting more timely, personalized, and effective management of atrial fibrillation.
Who Are The Top Performing Companies In The Atrial Fibrillation Devices Market In Recent Years?
Major companies operating in the atrial fibrillation devices market are Johnson & Johnson Services Inc., Abbott Laboratories, Medtronic Public Limited Company, Koninklijke Philips N.V., Boston Scientific Corporation, Shanghai MicroPort EP MedTech Co. Ltd., Japan Lifeline Co. Ltd., Microlife Corporation, AliveCor Inc., CardioFocus Inc., Imricor Medical Systems Inc., Kardium Inc., Stereotaxis Inc., Volta Medical, Synaptic Medical Corporation, Osypka AG, CathRx Ltd., BIOTRONIK SE & Co. KG, EP Solutions SA, CardiacSense Ltd.
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/atrial-fibrillation-devices-global-market-report
What Regional Growth Trends Are Shaping The Atrial Fibrillation Devices Market Outlook?
North America was the largest region in the atrial fibrillation devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the atrial fibrillation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Atrial Fibrillation Devices Market Report:
https://www.thebusinessresearchcompany.com/customise?id=25704&type=smp
Browse Through More Reports Similar to the Global Atrial Fibrillation Devices Market 2025, By The Business Research Company
Atrial Fibrillation Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/atrial-fibrillation-global-market-report
Cardiac Arrhythmia Monitoring Devices Global Market Report 2025
Ventricular Fibrillation Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/ventricular-fibrillation-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model